Associated Papers
Adenosine deaminase and interleukin-1 receptor antagonist genetic polymorphisms among obese children with versus without metabolic dysfunction-associated fatty liver disease.
Sakhr HM et al.
Clinical and Experimental Pediatrics, 2025
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.
Migliavacca M et al.
Nature Medicine, 2024
Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant.
Jennings MR et al.
Protein Expression and Purification, 2024
Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.
Klashami ZN et al.
Molecular Biology Reports, 2023
Does the adenosine deaminase (ADA) gene confer risk of sleepwalking?
Fournier S et al.
Journal of Sleep Research, 2022
Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach.
Mpoulimari I et al.
Psychiatric Genetics, 2022
Adenosine deaminase gene variant in diabetes and obesity.
Dayani SB et al.
Journal of Diabetes and Metabolic Disorders, 2022
ADA gene haplotype is associated with coronary-in-stent-restenosis.
Gholami M et al.
Molecular Biology Reports, 2021
Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelor.
Verdoia M et al.
Thrombosis Research, 2020
Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study.
Onishi A et al.
The Pharmacogenomics Journal, 2020
The molecular genetics of human sleep.
Zhang L et al.
The European Journal of Neuroscience, 2020
Exploring Genetic Data Across Individuals: Design and Evaluation of a Novel Comparative Report Tool.
Westendorf L et al.
Journal of Medical Internet Research, 2018
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.
Jenko B et al.
Frontiers in Pharmacology, 2018
Using variant databases for variant prioritization and to detect erroneous genotype-phenotype associations.
Broeckx BJG et al.
Bmc Bioinformatics, 2017
Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
Tode N et al.
Cancer Science, 2017
Maternal genetic polymorphisms and unexplained recurrent miscarriage: a systematic review and meta-analysis.
Shi X et al.
Clinical Genetics, 2017
Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients.
Farhan HM et al.
Central-european Journal of Immunology, 2017
Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS.
Salehabadi M et al.
Systems Biology in Reproductive Medicine, 2016
The Role of G22 A Adenosine Deaminase 1 Gene Polymorphism and the Activities of ADA Isoenzymes in Fertile and Infertile Men.
Fattahi A et al.
Urology, 2015
Whole genome sequencing of an ethnic Pathan (Pakhtun) from the north-west of Pakistan.
Ilyas M et al.
Bmc Genomics, 2015
G22A Polymorphism of Adenosine Deaminase and its Association with Biochemical Characteristics of Gestational Diabetes Mellitus in an Iranian Population.
Takhshid MA et al.
Iranian Journal of Medical Sciences, 2015
The functional polymorphism rs73598374:G>A (p.Asp8Asn) of the ADA gene is associated with telomerase activity and leukocyte telomere length.
Concetti F et al.
European Journal of Human Genetics : Ejhg, 2015
A comprehensive meta-analysis of common genetic variants in autism spectrum conditions.
Warrier V et al.
Molecular Autism, 2015
Disease variants in genomes of 44 centenarians.
Freudenberg-Hua Y et al.
Molecular Genetics & Genomic Medicine, 2014
The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in Chinese.
He HR et al.
International Journal of Molecular Sciences, 2014
Genetic psychophysiology: advances, problems, and future directions.
Anokhin AP
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology, 2014
Type-2 diabetes mellitus and the frequency of the G22A polymorphism of the adenosine deaminase gene in a mixed population in Brazil.
Domingos AC et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2014
Insights into behavioral vulnerability to differential sleep pressure and circadian phase from a functional ADA polymorphism.
Reichert CF et al.
Journal of Biological Rhythms, 2014
The circadian regulation of sleep: impact of a functional ADA-polymorphism and its association to working memory improvements.
Reichert CF et al.
Plos One, 2014
AKAPs integrate genetic findings for autism spectrum disorders.
Poelmans G et al.
Translational Psychiatry, 2013
Lack of association of the G22A polymorphism of the ADA gene in patients with ankylosing spondylitis.
Camargo U et al.
Genetics and Molecular Research : Gmr, 2012
Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans.
Bachmann V et al.
Cerebral Cortex (new York, N.y. : 1991), 2012
The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity.
Bachmann V et al.
Sleep, 2012
Adenosine deaminase polymorphism affects sleep EEG spectral power in a large epidemiological sample.
Mazzotti DR et al.
Plos One, 2012
Age- and gender-specific epistasis between ADA and TNF-α influences human life-expectancy.
Napolioni V et al.
Cytokine, 2011
Effects of the adenosine deaminase polymorphism and caffeine intake on sleep parameters in a large population sample.
Mazzotti DR et al.
Sleep, 2011
The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association.
Nunes DP et al.
Clinics (sao Paulo, Brazil), 2011
A study of three polymorphic sites of ADA gene in colon cancer.
Spina C et al.
Cancer Investigation, 2010
ADA (22G>A) polymorphism: a possible genetic marker for predictive medicine of human reproduction?
Napolioni V
Metabolism: Clinical and Experimental, 2010
Age- and gender-specific association between ADA (22G>A) and TNF-α (-308G>A) genetic polymorphisms.
Napolioni V et al.
Tissue Antigens, 2010
Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients.
Dutra GP et al.
Revista Brasileira De Psiquiatria (sao Paulo, Brazil : 1999), 2010
Gender-specific association of ADA genetic polymorphism with human longevity.
Napolioni V et al.
Biogerontology, 2010
Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT.
Bodenmann S et al.
Sleep, 2010
The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men.
Bodenmann S et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2009
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome.
Englund A et al.
Journal of Circadian Rhythms, 2009
The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo.
Riksen NP et al.
Pharmacogenetics and Genomics, 2008
The G22A polymorphism of the ADA gene and susceptibility to autism spectrum disorders.
Hettinger JA et al.
Journal of Autism and Developmental Disorders, 2008
Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis.
Campalani E et al.
The Journal of Investigative Dermatology, 2007
ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease.
Safranow K et al.
Cardiology, 2007
ADA polymorphisms and asthma: a study in the Chinese Han population.
Liu Y et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma, 2006